Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

908
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
908

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Türkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Kuwait and the United Arab Emirates: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019.

The Journal of antimicrobial chemotherapy·2025
Same author

Activity of mecillinam against USA urinary tract clinical isolates from 2017 to 2020 including isolates resistant to comparator antibiotics.

Journal of global antimicrobial resistance·2024
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
查看所有相关文章

相关实验视频

Updated: Jan 17, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
12:08

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium

Published on: February 14, 2022

3.3K

修改抗微生物敏感性测试方法的修改.

Ian Morrissey1, Jean B Patel2

  • 1Antimicrobial Focus Ltd., T15 Allen House, The Maltings, Sawbridgeworth, Herts CM21 9JX, UK.

The Journal of antimicrobial chemotherapy
|September 19, 2025
PubMed
概括
此摘要是机器生成的。

开发新的抗微生物药物需要可靠的抗微生物敏感性测试 (AST). 早期,科学证明的标准微稀释 (BMD) 方法的使用确保了准确的结果和及时的患者获取新药.

更多相关视频

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.6K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

20.0K

相关实验视频

Last Updated: Jan 17, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
12:08

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium

Published on: February 14, 2022

3.3K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.6K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

20.0K

科学领域:

  • 微生物学 微生物学
  • 传染性疾病 传染性疾病
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 抗微生物耐药性 (AMR) 需要开发新的抗微生物药物.
  • 可靠的抗微生物敏感性测试 (AST) 对于指导治疗决策和确保患者获得有效疗法至关重要.
  • 标准化的AST方法对于早期准确评估新型抗菌剂至关重要.

研究的目的:

  • 强调在开发新抗微生物药物的早期建立可靠的抗微生物敏感性测试 (AST) 方法的重要性.
  • 为了突出AST的标准参考方法:在阴离子调整的穆勒-亨顿 (CAMHB) 中微稀释 (BMD).
  • 提醒人们不要对参考AST方法进行科学上不合理的修改.

主要方法:

  • 遵守已确立的参考方法,如临床和实验室标准研究所 (CLSI) M07和国际标准化组织 (ISO) 20776-1,用于汁微稀释 (BMD).
  • 对标准AST协议进行任何必要修改的科学理由.
  • 在CLSI和欧洲抗菌感应性测试委员会 (EUCAST) 联合指南最终确定之前,使用参考方法严格评估抗菌剂.

主要成果:

  • 标准微稀释 (BMD) 方法在阴离子调整的穆勒-亨顿 (CAMHB) 是AST的参考.
  • 对 BMD 方法的修改必须具有科学有效性和临床相关性.
  • 不合理的修改可能导致不准确的最小抑制度 (MIC) 值,并阻碍药物开发.

结论:

  • 早期和深思熟虑地建立可靠的AST方法对于新抗菌剂的成功开发和临床采用至关重要.
  • 与参考AST方法的偏差应在科学上得到证明,以避免误导性结果和监管挑战.
  • 持续遵守标准化参考方法,如BMD,确保AST数据的完整性,并促进患者及时获得有效的治疗方法.